Parkinson's disease: Deep brain stimulation;Maladie de Parkinson: Stimulation cérébrale profonde

Revue Neurologique

Volumn 158, Issue SUPPL. 1, 2002, Pages

  Krack, P ^a,b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; DEGENERATIVE DISEASE; DYSKINESIA; GLOBUS PALLIDUS; HUMAN; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; NEUROSURGERY; PARKINSON DISEASE; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; SUBTHALAMIC NUCLEUS;

EID: 0036907386     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Albanese A, Bonucelli U, Brefel C, et al. (2001). Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease. Mov Disord, 16: 197-201.
2. Ardouin C, Pillon B, Peiffer E, et al. (1999). Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions. A consecutive series of 62 patients. Ann Neurol, 46: 217-223.
3. Beck At, Ward Ch, Mendelson M, Mack J, Erbaugh J. (1961). An inventory for measuring depression. Arch Gen Psychiatry, 4: 561-571.
4. Bejjani BP, Arnulf I, Demeret S, Damier P, Bonnet AM, Houeto JL, Agid Y. (2000a). Levodopa-induced dyskinesias in Parkinson's disease: Is sensitization reversible? Ann Neurol, 47: 655-658.
5. Bejjani BP, Dormont D, Pidoux B, et al. (2000b). Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg, 92: 615-625.
6. Benabid AL, Pollak P, Gervason C, Hoffmann D, Gao DM, Hommel M, De Rougemont J. (1991). Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet, 337: 403-406.
7. Benabid AL, Pollak P, Gross C, et al. (1994). Acute and long-term effects of subthalamic nucleus stimulation of Parkinsons disease. Stereotactic Funct Surg, 62: 76-84.
8. Benazzouz A, Breit S, Koudsie A, Pollak P, Krack P, Benabid AL. (2002). Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease. Mov Disord, 17, Suppl 3: 145-149.
9. Blond S, Touzet G, Krystkowiak P, Defèbvre L, Destée A. (2000). Le traitement neurochirurgical de la maladie de Parkinson: Quelle technique retenir ? Rev Neurol, 156, S2b: 257-269.
10. Charles D, Van Blercom N, Krack P, et al. (2002). Preoperative indicators of clinical outcome following bilateral subthalamic nucleus stimulation for the treatment of Parkinson's disease. Neurology (in press).
11. Defer GL, Widner H, Marie RM, Rémy P, Levivier M, and The Conference Participants (1999). Core assessment program for surgical interventional theapies in Parkinson's disease (CAPSITPD). Mov Disord, 14: 572-584.
12. Defer GL. (2000). Le traitement chirurgical: Critères d'inclusion. Rev Neurol, 156, S2b: 251-256.
13. Diederich NJ, Alesch F, Goetz CG. (2000). Visual hallucinations induced by deep brain stimulation in Parkinson's disease. Clin Neuropharmacol, 23: 287-289.
14. Dubois B, Slachevsky A, Litvan I, PILLON B. (2000). The FAB: A frontal assessment battery at bedside. Neurology, 55: 1613- 1620.
15. Fahn S, Elton RL. (1987). Unified Parkinson's disease rating scale. In Fahn S, Marsden CD, Calne D, and Goldstein M (eds.). Recent Developments in Parkinson's Disease, II. MacMillan Health Care Information, Florham Park, NJ. pp. 153-163.
16. Fraix V, Pollak P, Van Blercom N, Xie J, Krack P, Koudsie A, Benabid AL. (2000). Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease. Neurology, 55: 1921-1923.
17. Funkiewiez A, Caputo E, Ardouin C, Krack P, Fraix V, Benabid AL, Pollak R. (2001). Behavioral and mood changes associated with bilateral stimulation of the subthalamic nucleus: A consecutive series of 98 parkinsonian patients [abstract]. Neurology, 56, Suppl 3: A274
18. Hariz MI. (2002). Complications of deep brain stimulation surgery. Mov Disord, 17, Suppl 3: 162-166.
19. Houeto JL, Damier P, Bejjani PB, et al. (2000). Subthalamic stimulation in Parkinson disease. A multidisciplinary approach. Arch Neurol, 57: 461-465.
20. Houeto JL, Mesnage V, Mallet L, Pillon B, Gargiulo M, Tezenas DU, MONCEL S, Bonnet Am, Pidoux B, Dormont D, Cornu P, Agid Y. (2002). Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry, 72: 701-707.
21. Hutchison WD, Allan RJ, Opitz H, Levy R, Dostrovsky JO, Lang AE, Lozano Am. (1998). Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol, 44: 622-628.
22. Joint C, Nandi D, Parkin S, Gregory R, Aziz T. (2002). Hardware-related problems of deep brain stimulation. Mov Disord, 17, Suppl 3: 175-180.
23. Klawans HL. (1986). Individual manifestations of Parkinson's disease after ten or more years of levodopa. Mov Disord, 3: 187-192.
24. Krack P, Limousin P, Benabid AL, Pollak P. (1997a). Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease. Lancet, 350: 1676.
25. Krack P, Pollak P, Limousin P, Benazzouz A, Benabid AL. (1997b). Stimulation of subthalamic nucleus alleviates tremor in Parkinson's disease. Lancet, 350: 1675.
26. Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A, Benabid Al. (1998). Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain, 121: 451-457.
27. Krack P, Pollak P, Limousin P, Benazzouz A, Deuschl G, Benabid Al. (1999). From off-period dystonia to peak-dose chorea: The clinical spectrum of varying subthalamic nucleus activity. Brain, 122: 1133-1146.
28. Krack P, Ardouin C, Funkiewiez A, Caputo E, Benazzouz A, Benabid AL, Pollak P. (2001a). What is the influence of STN stimulation on the limbic loop? In Kultas-Ilinsky K and Ilinsky IA (eds.). Basal Ganglia and Thalamus in Health and Movement Disorders, pp. 333-340. Kluwer Academic/Plenum Publishers, New York.
29. Krack P, Kumar R, Ardouin C, Limousin Dowsey P, McVicker JM, Benabid Al, Pollak P. (2001 b). Mirthful laughter induced by subthalamic nucleus stimulation. Mov Disord, 16: 867-875.
30. Krack P, Fraix V, Mendes A, Benabid AL, Pollak P. (2002). Post-operative management of subthalamic nucleus stimulation for Parkinson's disease. Mov Disord, 17, Suppl 3: 188-197.
31. Kumar R, Lozano AM, Kim YJ, Hutchison WD, Sime E, Halket E, Lang AE. (1998). Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology, 51: 850-855.
32. Lagrance E, Moro E, Ardouin C, Van Blercom N, Pollak P. (2001). Quality-of-life benefit induced by bilateral subthalamic stimulation in patients with Parkinson's disease [abstract]. Neurology, 56, Suppl 3: A275.
33. Limousin P, Pollak P, Benazzouz A, et al. (1995). Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet, 345: 91-95.
34. Limousin P, Pollak P, Hoffmann D, Benazzouz A, Benabid AL. (1996). Abnormal involuntary movements induced by subthalamic nucleus stimulation in parkinsonian patients. Mov Disord, 11: 231-235.
35. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL. (1998). Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med, 339: 1105-1111.
36. Marconi R, Lefèbvre-Caparros D, Bonnet A, Vidailhet M, Dubois B, Agid Y. (1994). Levodopa-induced dyskinesias in Parkinsons disease. Phenomenology and pathophysiology. Mov Disord, 9: 2-12.
37. Merello M, Cammarota A, Leiguarda R, Pikielny R. (2001). Delayed intracerebral electrode infection after bilateral STN implantation for Parkinson's disease. Mov Disord, 16: 168-170.
38. Molinuevo Jl, Valldeoriola F, Tolosa E, Rumia J. (2000). Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson's disease. Arch Neurol, 57: 983-988.
39. Moro E, Scerrati M, Romito LMA, Roselli R, Tonali P, Albanese A. (1999). Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology, 53: 85-90.
40. Nutt JG, Anderson VC, Peacock JH, Hammerstad JP, Burchiel KJ. (2001). DBS and diathermy interaction induces severe CNS damage. Neurology, 56: 1384-1386.
41. Pillon B. (2002). Neuropsychological assessment for management of patients with deep brain stimulation. Mov Disord, 17, Suppl 3: S116-S122.
42. Pollak P, Benabid AL, Krack P, Limousin P, Benazzouz A. (1998). Deep brain stimulation. In Jankovic J and Tolosa E (eds.). Parkinson's Disease and Movement Disorders. Williams & Wilkins, Baltimore. pp. 1085-1101.
43. Pollak P, Fraix V, Krack P, et al. (2002a). Treatment results: Parkinson's disease. Mov Disord, 17, Suppl 3: 75-83.
44. Pollak P, Krack P, Fraix V, Mendes A, Moro E, Chabardes S, Benabid AL. (2002b). Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson's disease. Mov Disord, 17, Suppl 3: 155-161.
45. Recommandations du jury (2000). Conférence de consensus: La maladie de Parkinson. Rev Neurol, 156 S2b: 274-280.
46. Saint-Cyr JA, Trepanier LL, Kumar R, Lozano A. (2000). Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain, 123: 2091-2108.
47. Schmidt R, Freidl W, Fazekas F, et al. (1994). The Mattis dementia rating scale: Normative data from 1,001 healthy volunteers. Neurology, 44: 964-966.
48. Schuurman PR, Bosch DA, Bossuyt PMM, et al. (2000). A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med, 342: 461-468.
49. Speelman JD. (1991). Parkinson's disease and stereotaxic neurosurgery [thèse scientifique de I'Université d'Amsterdam], Rodopi, Amsterdam. pp25-26.
50. Stolze H, Klebe S, Poepping M, et al. (2001). Effects of bilateral subthalamic nucleus stimulation on gait in advanced Parkinson's disease. Neurology, 57: 144-146.
51. The Deep-Brain Stimulation for Parkinson's Disease Study Group (2001). Deep brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med, 345: 956-963.
52. Tronnier VM, Straubert A, Hahnel S, Sarem-Aslani A. (1999). Magnetic resonance imaging with implanted neurostimulators: An in vitro and in vivo study. Neurosurgery, 44: 118-126 discussion 125-6.
53. Van Blercom N, Charles D, Limousin P, et al. (1999). Long-term bilateral subthalamic nucleus stimulation for the treatment of Parkinson's disease [abstract]. Neurology, 52, Suppl 2: A271.
54. Volkmann J, Allert N, Voges J, Weiss PH, Freund HJ, Sturm V. (2001). Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD. Neurology, 56: 548-551.
55. Volkmann J, Herzog J, Kopper F, Deuschl G. (2002). Introduction to the programming of deep brain stimulators. Mov Disord, 17, Suppl 3: S181-S187.
56. Welter ML, Houeto JL, Tezenas Du Montcel S, et al. (2002). Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain, 125: 575-583.
57. Wenzelburger R, Zhang BR, Poepping M, et al. (2002). Dyskinesias and grip control in Parkinson's disease are normalized by chronic stimulation of the subthalamic nucleus. Ann Neurol (in press).